The Valley Desk

NCT01078454 · Interventional trial

Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis

Overall registry status Completed

Phase 3

Conditions Light Chain Deposition Disease, Primary Systemic Amyloidosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov